Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 ,inter alia, to consider and approve the unaudited financial results (standalone) of the Company for the quarter ended on June 30, 2025.